Molecular cytogenetics of lymphoid malignancies; molecular cloning of translocation breakpoints; gene identification: functional analysis of novel genes, particularly in relation to apoptotic pathways; application to routine diagnostic clinical material.
Antibody therapy of lymphoid malignancies; assessment of optimal antibody constructs for therapy, identification of novel targets for therapy.
Development and assessment of novel agents for therapy of B-cell malignancies.